Law360, Washington (November 16, 2016, 6:37 PM EST) -- The Coalition for Affordable Drugs pressed a Patent Trial and Appeal Board panel Wednesday to scrap a patent covering Pozen Inc.'s arthritis and ulcer drug Vimovo during an America Invents Act review, arguing that the claims would have been obvious to skilled artisans in light of existing studies and patents.
Counsel for the organization, which was started by hedge fund manager Kyle Bass, told the three-judge panel during an inter partes review that an inventor looking to reduce the incidence of gastric ulcers in patients on a low-aspirin regimen would need only look to a 2005 patent known as "Plachetka," or...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!